查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1481832

全球粪便移植治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Fecal Transplant Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

全球粪便移植治疗市场需求预计将从 2023 年的 18.9 亿美元达到近 32.4 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.18%。

粪便移植疗法或粪便微生物移植 (FMT) 是一种医疗程序，涉及将健康捐赠者的粪便物质转移到受体的胃肠道中，以恢復肠道微生物群的健康平衡。此疗法主要治疗復发性艰难梭菌（C. difficile）感染，这是一种导致严重腹泻和胃肠道症状的细菌感染。这种疗法的原理是将供体粪便中的有益细菌和微生物重新引入受体肠道，这有助于抑制艰难梭菌等有害细菌的生长，并恢復微生物多样性和平衡。这种疗法在治疗復发性艰难梭菌感染方面显示出很高的成功率，并且正在研究其在其他胃肠道疾病和病症中的潜在应用。

市场动态

肠躁症 (IBD)、艰难梭菌感染 (CDI) 和肠躁症 (IBS) 等胃肠道疾病的流行，推动了对创新治疗方案的需求。人们对肠-脑轴以及肠道微生物群在监督免疫功能、代谢和神经健康方面的作用的日益了解，引起了人们对粪便移植疗法的兴趣，将其作为治疗抑郁症、自闭症谱系障碍和帕金森氏症等疾病的潜在治疗方法。此外，粪便处理技术的进步，例如冷冻、冷冻干燥或胶囊製剂，正在提高粪便移植产品的便利性、稳定性和标准化，从而促进该疗法的更广泛采用和可扩展性。此外，粪便移植治疗的支持性监管框架和指南，加上医疗保健支付者报销范围的扩大，正在消除准入障碍并推动市​​场扩张。此外，基于微生物组的诊断和个人化医疗方法的出现为粪便移植治疗创造了新的机会，作为根据个别患者的微生物组概况和医疗需求量身定制的综合治疗策略的一部分。然而，微生物组研究和替代治疗方式的进步可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球粪便移植治疗市场的每个细分市场进行了包容性评估。粪便移植治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

粪便移植治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按疾病分类

  • 艰难梭菌感染
  • 自闭症、肥胖
  • 帕金森氏症 (PD)
  • 糖尿病
  • 其他的

按程式

  • 粪便灌肠
  • 粪便细菌治疗
  • 粪便移植
  • 人类用益生菌输液
  • 粪便输血

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲粪便移植治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。粪便移植治疗市场的主要参与者包括Finch Therapeutics、Rebiotix、Vedanta Biosciences、Seres Therapeutics、杜邦营养与生物科学、OpenBiome、Evelo Biosciences、Microbiome Therapeutics、Daewoong Pharmaceutical、Takecroda Pharmaceutical Company、MaaTbio、BiomX、Mssecrod ，CIPAC疗法。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：粪便移植治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按疾病分类的市场吸引力分析
    • 按程式进行的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球粪便移植治疗市场分析：依疾病分类

  • 按疾病分类概述
  • 历史和预测数据
  • 按疾病分析
  • 艰难梭菌感染
  • 自闭症、肥胖
  • 帕金森氏症 (PD)
  • 糖尿病
  • 其他的

第 6 章：全球粪便移植治疗市场分析：按程序

  • 按程序概述
  • 历史和预测数据
  • 按程序分析
  • 粪便灌肠
  • 粪便细菌治疗
  • 粪便移植
  • 人类用益生菌输液
  • 粪便输血

第 7 章：全球粪便移植治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：粪便移植治疗公司的竞争格局

  • 粪便移植治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Finch Therapeutics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Rebiotix
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Vedanta Biosciences
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Seres Therapeutics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • DuPont Nutrition & Biosciences
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • OpenBiome
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Evelo Biosciences
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Microbiome Therapeutics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Daewoong Pharmaceutical
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Takeda Pharmaceutical Company
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MaaT Pharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BiomX
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Assembly Biosciences
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Microbiotica
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • CIPAC Therapeutics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114443

The global demand for Fecal Transplant Therapy Market is presumed to reach the market size of nearly USD 3.24 Billion by 2032 from USD 1.89 Billion in 2023 with a CAGR of 6.18% under the study period 2024-2032.

Fecal transplant therapy, or fecal microbiota transplantation (FMT), is a medical procedure involving fecal matter from a healthy donor that is transferred into a recipient's gastrointestinal tract to reinstate a healthy balance of gut microbiota. This therapy primarily treats recurrent Clostridium difficile (C. difficile) infections, a bacterial infection that causes severe diarrhea and gastrointestinal symptoms. This therapy works by reintroducing beneficial bacteria and microorganisms from the donor's stool into the recipient's gut, which helps suppress the growth of harmful bacteria such as C. difficile and restore microbial diversity and balance. This therapy has shown high success rates in treating recurrent C. difficile infections and is being investigated for its potential applications in other gastrointestinal disorders and conditions.

MARKET DYNAMICS

The spurring prevalence of gastrointestinal disorders, such as inflammatory bowel disease (IBD), clostridium difficile infection (CDI), and irritable bowel syndrome (IBS), is driving the demand for innovative treatment options. The increasing understanding of the gut-brain axis and the role of gut microbiota in overseeing immune function, metabolism, and neurological health drives interest in fecal transplant therapy as a potential therapeutic approach for conditions such as depression, autism spectrum disorders, and Parkinson's disease. Moreover, advancements in fecal processing techniques, such as frozen, lyophilized, or encapsulated formulations, are improving the convenience, stability, and standardization of fecal transplant products, thereby facilitating broader adoption and scalability of the therapy. Furthermore, supportive regulatory frameworks and guidelines for fecal transplant therapy, coupled with increasing reimbursement coverage by healthcare payers, are removing barriers to access and driving market expansion. Additionally, the emergence of microbiome-based diagnostics and personalized medicine approaches is creating new opportunities for fecal transplant therapy as part of comprehensive treatment strategies tailored to individual patients' microbiome profiles and medical needs. However, advancements in microbiome research and alternative treatment modalities may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fecal Transplant Therapy. The growth and trends of Fecal Transplant Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fecal Transplant Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease

  • Clostridium Difficile Infection
  • Autism, Obesity
  • Parkinson's Disease (PD)
  • Diabetes Mellitus
  • Others

By Procedure

  • Fecal Enema
  • Fecal Bacteriotherapy
  • Stool Transplant
  • Human Probiotic Infusion
  • Fecal Transfusion

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fecal Transplant Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fecal Transplant Therapy market include Finch Therapeutics, Rebiotix, Vedanta Biosciences, Seres Therapeutics, DuPont Nutrition & Biosciences, OpenBiome, Evelo Biosciences, Microbiome Therapeutics, Daewoong Pharmaceutical, Takeda Pharmaceutical Company, MaaT Pharma, BiomX, Assembly Biosciences, Microbiotica, CIPAC Therapeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FECAL TRANSPLANT THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By Procedure
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FECAL TRANSPLANT THERAPY MARKET ANALYSIS BY DISEASE

  • 5.1. Overview By Disease
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Disease
  • 5.4. Clostridium Difficile Infection Historic and Forecast Sales By Regions
  • 5.5. Autism, Obesity Historic and Forecast Sales By Regions
  • 5.6. Parkinson's Disease (PD) Historic and Forecast Sales By Regions
  • 5.7. Diabetes Mellitus Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL FECAL TRANSPLANT THERAPY MARKET ANALYSIS BY PROCEDURE

  • 6.1. Overview By Procedure
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Procedure
  • 6.4. Fecal Enema Historic and Forecast Sales By Regions
  • 6.5. Fecal Bacteriotherapy Historic and Forecast Sales By Regions
  • 6.6. Stool Transplant Historic and Forecast Sales By Regions
  • 6.7. Human Probiotic Infusion Historic and Forecast Sales By Regions
  • 6.8. Fecal Transfusion Historic and Forecast Sales By Regions

7. GLOBAL FECAL TRANSPLANT THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE FECAL TRANSPLANT THERAPY COMPANIES

  • 8.1. Fecal Transplant Therapy Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF FECAL TRANSPLANT THERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Finch Therapeutics
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Rebiotix
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Vedanta Biosciences
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Seres Therapeutics
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. DuPont Nutrition & Biosciences
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. OpenBiome
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Evelo Biosciences
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Microbiome Therapeutics
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Daewoong Pharmaceutical
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Takeda Pharmaceutical Company
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. MaaT Pharma
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. BiomX
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Assembly Biosciences
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Microbiotica
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. CIPAC Therapeutics
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease (USD MN)
  • Clostridium Difficile Infection Market Sales By Geography (USD MN)
  • Autism, Obesity Market Sales By Geography (USD MN)
  • Parkinson's Disease (PD) Market Sales By Geography (USD MN)
  • Diabetes Mellitus Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Procedure (USD MN)
  • Fecal Enema Market Sales By Geography (USD MN)
  • Fecal Bacteriotherapy Market Sales By Geography (USD MN)
  • Stool Transplant Market Sales By Geography (USD MN)
  • Human Probiotic Infusion Market Sales By Geography (USD MN)
  • Fecal Transfusion Market Sales By Geography (USD MN)
  • Global Fecal Transplant Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Fecal Transplant Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Fecal Transplant Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By Procedure
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease (USD MN)
  • Clostridium Difficile Infection Market Sales By Geography (USD MN)
  • Autism, Obesity Market Sales By Geography (USD MN)
  • Parkinson's Disease (PD) Market Sales By Geography (USD MN)
  • Diabetes Mellitus Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Procedure (USD MN)
  • Fecal Enema Market Sales By Geography (USD MN)
  • Fecal Bacteriotherapy Market Sales By Geography (USD MN)
  • Stool Transplant Market Sales By Geography (USD MN)
  • Human Probiotic Infusion Market Sales By Geography (USD MN)
  • Fecal Transfusion Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.